No Data
Konat medical (688314.SH): The work of localizing the production of PEEK material bone plates in the United States is still steadily progressing, and it is expected to achieve on-site production by 2024.
Gelonghui, August 21st | Kantor Medical (688314.SH) stated on the investor interaction platform that the overall machining and surface treatment of BIOPLATE titanium materials at its US subsidiary has now been transferred to domestic factories. The work on the localization production of PEEK material bone plates in the USA is still steadily progressing and is expected to be achieved by 2024.
Konfo Medical (688314.SH): The imported PEEK material is used in the research project "Polyether ether ketone cranial fixation system".
On August 14, Gelonhui reported that Kangtuo Medical (688314.SH) is currently using imported PEEK material for its research project on "polyetheretherketone cranial fixation system".
Interim report of Xi'an Kangtuo Medical Technology Co., Ltd. in 2024.
Summary of the semi-annual report of Xi'an Kangtuo Medical Technology Co., Ltd. in 2024
Kangtuo Medical (688314.SH): Director Hu Liren increased his shareholding by 0.14%.
On June 7th, Gelunhui reported that Kangtuo Medical (688314.SH) had received a Notice of Shareholding Increase from its controlling shareholder, actual controller, and chairman Mr. Hu Liren. Based on his firm confidence in the company's sustained and stable development in the future and his high recognition of the company's long-term value, Mr. Hu Liren used his personal funds to increase his shareholding in the company by 110,000 shares through centralized bidding on the Shanghai Stock Exchange trading system, accounting for 0.14% of the company's total share capital.
Kangtuo Medical (688314.SH) 2023 equity distribution: 0.32 yuan per share, share registration on May 28
Kangtuo Medical (688314.SH) issued the 2023 equity distribution implementation notice. This time, profits are distributed to Israel...
No Data
No Data